Immune Pharmaceuticals

Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
PharmaLive
Sun, 02/24/13 - 02:40 pm
Immune Pharmaceuticals
bertilimumab
ulcerative colitis
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Yahoo
Thu, 02/21/13 - 11:09 am
Immune Pharmaceuticals
ulcerative colitis
bertilimumab
Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
Yahoo
Thu, 11/8/12 - 10:51 am
M&A
EpiCept
Immune Pharmaceuticals